Publish Ahead of Print

Original Article

Can we downstage locally advanced pancreatic cancer to resectable? A phase I/II study of induction oxaliplatin and 5-FU chemoradiation
Salvatore Amodeo, Antonio Masi, Marcovalerio Melis, Theresa Ryan, Howard S. Hochster, Deirdre J. Cohen, Anurag Chandra, H. Leon Pachter, Elliot Newman
Current survival and treatment trends for surgically resected intrahepatic cholangiocarcinoma in the United States
Ariella M. Altman, Scott Kizy, Schelomo Marmor, Jing Li Huang, Jason W. Denbo, Eric H. Jensen
Walking to recovery: the effects of missed ambulation events on postsurgical recovery after bowel resection
Trent W. Stethen, Yasir A. Ghazi, Robert Eric Heidel, Brian J. Daley, Linda Barnes, Donna Patterson, James M. McLoughlin
Outcomes of patients in the national cancer database treated non-surgically for localized rectal cancer
Emma B. Holliday, Pamela K. Allen, Hesham Elhalawani, Omar Abdel-Rahman
Overexpression of SSH1 in gastric adenocarcinoma and its correlation with clinicopathological features
Seyedeh Saideh Daryabari, Reza Safaralizadeh, Mohammadali Hosseinpourfeizi, Yaghoub Moaddab, Behrooz Shokouhi
A case-control study of the association between metabolic syndrome and colorectal cancer: a comparison of International Diabetes Federation, National Cholesterol Education Program Adults Treatment Panel III, and World Health Organization definitions
Vaidehi Ulaganathan, Mirnalini Kandiah, Zalilah Mohd Shariff
Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer
Brandon R. Mancini, Stacey Stein, Shane Lloyd, Charles E. Rutter, Edward James, Bryan W. Chang, Jill Lacy, Kimberly L. Johung
Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer
Michael Chuong, Shahed N. Badiyan, Man Yam, Zuofeng Li, Katja Langen, William Regine, Christopher Morris, James Snider III, Minesh Mehta, Soon Huh, Michael Rutenberg, Romaine C. Nichols
Neoadjuvant PET and MRI-based intensity modulated radiotherapy leads to less toxicity and improved pathologic response rates in locally advanced rectal cancer
John M. David, Gillian Gresham, Salma K. Jabbour, Matthew Deek, Shant Thomassian, John M. Robertson, Neil B. Newman, Joseph M. Herman, Arsen Osipov, Peyman Kabolizadeh, Richard Tuli
Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma
Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Mauro Daniel Spina Donadio, Audrey Cabral, Thiago Pimentel Muniz, Luciana de Moura Leite, Lucas Ferreira Sant’Ana
Chemotherapy re-challenge response rate in metastatic colorectal cancer
Alexandra E. Chambers, Jacob Frick, Natalee Tanner, Richard Gerkin, Madappa Kundranda, Tomislav Dragovich
Clinicopathologic features and outcomes of gastrointestinal stromal tumors arising from the esophagus and gastroesophageal junction
Andrew M. Briggler, Rondell P. Graham, Gustavo F. Westin, Andrew L. Folpe, Dawn E. Jaroszewski, Scott H. Okuno, Thorvardur R. Halfdanarson
KRAS, NRAS and BRAF analysis of ampullary adenocarcinoma classified using CK7, CK20, MUC1 and MUC2
Marwa Ferchichi, Raja Jouini, Imen Ayari, Wafa Koubaa, Aschraf Chadli-Debbiche, Ehsen BenBrahim
Anastomotic leak and neoadjuvant chemoradiotherapy in esophageal cancer
Ravi Shridhar, Caitlin Takahashi, Jamie Huston, Matthew P. Doepker, Kenneth L. Meredith
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition
David A. Fabrizio, Thomas J. George Jr, Richard F. Dunne, Garrett Frampton, James Sun, Kyle Gowen, Mark Kennedy, Joel Greenbowe, Alexa B. Schrock, Aram F. Hezel, Jeffrey S. Ross, Phillip J. Stephens, Siraj M. Ali, Vincent A. Miller, Marwan Fakih, Samuel J. Klempner
Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis
Whitney Guerrero, Gitonga Munene, Paxton V. Dickson, Zachary E. Stiles, Johnathan Mays, Andrew M. Davidoff, Evan S. Glazer, David Shibata, Jeremiah L. Deneve
Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas
Muhammad M. Fareed, Lyudmila DeMora, Nestor F. Esnaola, Crystal S. Denlinger, Andreas Karachristos, Eric E. Ross, John Hoffman, Joshua E. Meyer
Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United States
Waqar Haque, Vivek Verma, E. Brian Butler, Bin S. Teh
The incidence of colorectal cancer in patients with previously removed polyp(s)—a cross-sectional study
Ruud J. L. F. Loffeld, Boris Liberov, Pascale E. P. Dekkers
Is there an optimal staging system or liver reserve model that can predict outcome in hepatocellular carcinoma?
Veeravich Jaruvongvanich, Tomoki Sempokuya, Linda Wong
Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma
Homan Mohammadi, Yazan Abuodeh, William Jin, Jessica Frakes, Mark Friedman, Benjamin Biebel, Junsung Choi, Ghassan El-Haddad, Bela Kis, Jennifer Sweeney, Sarah Hoffe
Stereotactic body radiation therapy following transarterial chemoembolization for unresectable hepatocellular carcinoma
Michael Buckstein, Edward Kim, Aaron Fischman, Seth Blacksburg, Marcelo Facciuto, Myron Schwartz, Kenneth Rosenzweig
Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
Kei Moriya, Tadashi Namisaki, Shinya Sato, Akitoshi Douhara, Masanori Furukawa, Hideto Kawaratani, Kosuke Kaji, Mitsuteru Kitade, Naotaka Shimozato, Yasuhiko Sawada, Kenichiro Seki, Soichiro Saikawa, Hiroaki Takaya, Takemi Akahane, Akira Mitoro, Yasushi Okura, Junichi Yamao, Hitoshi Yoshiji
Role of lymph node ratio in selection of adjuvant treatment (chemotherapy vs. chemoradiation) in patients with resected gastric cancer
Brice Jabo, Matthew J. Selleck, John W. Morgan, Sharon S. Lum, Khaled Bahjri, Mayada Aljehani, Carlos A. Garberoglio, Mark E. Reeves, Jukes P. Namm, Naveenraj L. Solomon, Fabrizio Luca, Gary Yang, Maheswari Senthil
Study of Cofilin1 gene expression in colorectal cancer
Samira Mousavi, Reza Safaralizadeh, Mohammadali Hosseinpour-Feizi, Arash Azimzadeh-Isfanjani, Shahryar Hashemzadeh
The value of oxaliplatin in the systemic treatment of locally advanced rectal cancer
Teresa Martín-Aragón, Javier Serrano, Juana Benedí, Rosa M. Meiriño, Pilar García-Alonso, Felipe A. Calvo
Impact of intensity modulated radiation therapy on survival in anal cancer
Jaymin Jhaveri, Lael Rayfield, Yuan Liu, Mudit Chowdhary, Sibo Tian, Richard J. Cassidy, Theresa Gillespie, Pretesh R. Patel, Jerome C. Landry, Kirtesh R. Patel
Morbidity and mortality of synchronous hepatectomy with cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
Tyler J. Mouw, Jennifer Lu, Meghan Woody-Fowler, John Ashcraft, Joseph Valentino, Peter DiPasco, Joshua Mammen, Mazin Al-Kasspooles
Anaemia and its effects on tumour regression grade and survival following chemotherapy in adenocarcinoma of the oesophagus
Alexander N. C. Boucher, Oliver Ng, John H. Saunders, Austin G. Acheson, Simon L. Parsons
Endoscopic stenting should be advocated in patients with stage IV colorectal cancer presenting with acute obstruction
Tian-Zhi Lim, Dedrick Kok Hong Chan, Ker-Kan Tan
Retrospective analysis of efficacy and safety of Gemcitabinebased chemotherapy in patients with metastatic pancreatic adenocarcinoma experiencing disease progression on FOLFIRINOX
Victor Hugo Fonseca de Jesus, Marcos Pedro Guedes Camandaroba, Mauro Daniel Spina Donadio, Audrey Cabral, Thiago Pimentel Muniz, Luciana de Moura Leite, Lucas Ferreira Sant’Ana
Exploring the differences between early-onset gastric cancer and traditional-onset gastric cancer
Anwar Giryes, Hani Oweira, Meinrad Mannhart, Michael Decker, Omar Abdel-Rahman
Reclassification of lesions in biopsies by fine-needle aspiration of pancreas and biliary tree using Papanicolaou classification
Adriana N. López-Ramírez, Lidia F. Villegas-González, Mónica L. Serrano-Arévalo, Lorena Flores-Hernández, Leonardo S. Lino-Silva, Ludwig E. González-Mena
Differences in overall survival and mutation prevalence between right- and left-sided colorectal adenocarcinoma
Christopher E. Jensen, Jonathan Y. Villanueva, Arturo Loaiza-Bonilla
Single institution experience of sorafenib for advanced HCC in a US tertiary care hospital
V. V. Pavan Kedar Mukthinuthalapati, Yuchen Wang, Yazan Abu Omar, Moin Syed, Bashar Attar

Review Article

Proton beam therapy for gastrointestinal cancers: past, present, and future
Shahed N. Badiyan, Christopher L. Hallemeier, Steven H. Lin, Matthew D. Hall, Michael D. Chuong
Accuracy of endoscopic ultrasound staging for T2N0 esophageal cancer: a national cancer database analysis
Ravi Shridhar, Jamie Huston, Kenneth L. Meredith
Review and current state of radiation therapy for locally advanced pancreatic adenocarcinoma
Adriana Blakaj, Stacey M. Stein, Sajid A. Khan, Kimberly L. Johung
The gut microbiome and colorectal cancer: a review of bacterial pathogenesis
Jessica D. Dahmus, Drew L. Kotler, David M. Kastenberg, C. Andrew Kistler
The role of lineage specifiers in pancreatic ductal adenocarcinoma
Soledad A. Camolotto, Veronika K. Belova, Eric L. Snyder
Advances in surgery for pancreatic cancer
Alexandra W. Acher, Josh Bleicher, Austin Cannon, Courtney Scaife
Combination immunotherapy and radiation therapy strategies for pancreatic cancer—targeting multiple steps in the cancer immunity cycle
Snehal Gajiwala, Anna Torgeson, Ignacio Garrido-Laguna, Conan Kinsey, Shane Lloyd
Large database utilization in health outcomes research in pancreatic cancer: an update
Anna Torgeson, Randa Tao, Ignacio Garrido-Laguna, Benjamin Willen, Amy Dursteler, Shane Lloyd
Stereotactic body radiation therapy in primary hepatocellular carcinoma: current status and future directions
Timothy A. Lin, Jessica S. Lin, Timothy Wagner, Ngoc Pham

Case Report

Exceptional response to FOLFIRINOX in a patient with pancreatic cancer and a germline RAD51C mutation
Sofia Palacio, Terri Pollack, Rachel Silva-Smith, Daniel A. Sussman, Peter J. Hosein
Unresectable metastatic colorectal cancer patient cured with cetuximab-based chemotherapy: a case report with new molecular insights
Romain Cohen, Marine Sroussi, Camilla Pilati, Sidney Houry, Pierre Laurent-Puig, Thierry André
Brain metastasis and herniation in a patient with ampullary adenocarcinoma presenting with jaundice and memory loss: case report
Abdullah Saleh ALQattan, Omar Ali AL-Ghamdi, Mumtaz Sarang, Mohammed Saad AL-Qahtani

Short Communication

Multiple primary malignancies in patients with anal squamous cell carcinoma
Diana Li, Nikhil Yegya-Raman, Sinae Kim, Shridar Ganesan, Mutlay Sayan, David August, Kristen Spencer, Lara Hathout, Nell Maloney-Patel, Usha Malhotra, Ning J. Yue, Salma K. Jabbour